Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies (Q28210611)

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

Europe PubMed Central

title

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies (English)

0 references

1 reference

1 reference

1 reference

Enrico Flossmann

1

0 references

Peter M Rothwell

series ordinal

2

0 references

language of work or name

English

0 references

publication date

12 May 2007

0 references

published in

The Lancet

0 references

volume

369

0 references

issue

9573

0 references

page(s)

1603-13

0 references

1 reference

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Celecoxib for the prevention of colorectal adenomatous polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Clinical practice. Adenomatous polyps of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Classification tree analysis: a statistical tool to investigate risk factor interactions with an example for colon cancer (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly with Smoking and Nonsteroidal Anti-inflammatory Drug Use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Drugs and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Nonsteroidal antiinflammatory drugs and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Analgesic Use and Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Nonsteroidal Anti-inflammatory Drugs and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Lifestyle factors and Ki-ras mutations in colon cancer tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use, cancer, and polyps of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Risk factors for fatal colon cancer in a large prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

The association between aspirin use and the incidence of colorectal cancer in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and incidence of large-bowel cancer in a California retirement community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and Colorectal Cancer: The Leisure World Cohort Revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Long-term diuretic therapy in patients with coronary disease: increased colon cancer-related mortality over a 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Colorectal cancer after start of nonsteroidal anti-inflammatory drug use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Use of NSAIDs for the Chemoprevention of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and cancer risk: an updated quantitative review to 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Long term hormone therapy for perimenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Reliability of cancer registration data in Scotland, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Registration of colorectal cancer in Scotland: An assessment of data accuracy based on review of medical records

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Reliability of data of the Thames cancer registry on 673 cases of colorectal cancer: effect of the registration process.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Suppression of azoxymethane-induced colon cancer development in rats by a cyclooxygenase-1 selective inhibitor, mofezolac

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

1 reference

7 January 2021

Approaches and opportunities in colon-specific drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960747-8

7 January 2021

10.1016/S0140-6736(07)60747-8

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17499602

1 reference

Consolidated OpenCitations Corpus – April 2017